Enzymatic Activity, Sensitivity to Antifungal Drugs and Baccharis dracunculifolia Essential Oil by Candida Strains Isolated from the Oral Cavities of Breastfeeding Infants and in Their Mothers' Mouths and Nipples

Mycopathologia

Volumn 171, Issue 2, 2011, Pages 103-109

  Pereira, Cristiane Aparecida ^a   da Costa, Anna Carolina Borges Pereira ^a   Machado, Ana Karina Silva ^a   Júnior, Miltom Beltrame ^c   Zöllner, Maria Stella Amorin Costa ^b   Junqueira, Juliana Campos ^a   Jorge, Antonio Olavo Cardoso ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF TAUBATÉ   (Brazil)

^c INSTITUTO DE PESQUISA E DESENVOLVIMENTO   (Brazil)

Author keywords

Amphotericin B; Baccharis dracunculifolia; Candida; Fluconazole; Phospholipase; Proteinase

Indexed keywords

BACCHARIS DRACUNCULIFOLIA; CANDIDA; CANDIDA ALBICANS;

EID: 78651426438     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-010-9353-y     Document Type: Article

References (42)

1. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol. 2001; 9(7): 327-35. doi: 10. 1016/S0966-842X(01)02094-7.
2. Tanguay KE, McBean MR, Jain E. Nipple candidiasis among breastfeeding mothers. Case-control study of predisposing factors. Can Fam Physician. 1994; 40: 1407-13.
3. Heinig MJ, Francis J, Pappagianis D. Mammary candidosis in lactating women. J Hum Lact. 1999; 15(4): 281-8. doi: 10. 1177/089033449901500402.
4. Amir LH, Pakula S. Nipple pain, mastalgia and candidiasis in the lactating breast. Aus N Z J Obstet Gynaecol. 1991; 31(4): 378-80.
5. Yang YL. Virulence factors of Candida species. J Microbiol Immunol Infect. 2003; 36(4): 223-8.
6. Samaranayake YH, Dassanayake RS, Jayatilake JA, Cheung BP, Yau JY, Yeung KW, Samaranayake LP. Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection. J Med Microbiol. 2005; 54(Pt 6): 583-93. doi: 10. 1099/jmm. 0. 45762-0.
7. Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 2005; 48(6): 365-77. doi: 10. 1111/j. 1439-0507. 2005. 01165. x.
8. Chandrasekaran M, Venkatesalu V. Antibacterial and antifungal activity of Syzygium jambolonum seeds. J Ethopharmacol. 2004; 91: 105-8. doi: 10. 1016/j. jep. 2003. 12. 012.
9. Eloff JN. Wich extractant should be used for the screening and isolation of antimicrobial components from plants? J Ethnopharmacol. 1988; 60: 1-8. doi: 10. 1016/S0378-8741(97)00123-2.
10. De Barros MP, Sousa JP, Bastos JK, De Andrade SF. Effect of Brazilian green propolis on experimental gastric ulcers in rats. J Ethnopharmacol. 2007; 110(3): 567-71. doi: 10. 1016/j. jep. 2006. 10. 022.
11. Simões LM, Gregório LE, Da Silva Filho AA, de Souza ML, Azzolini AE, Bastos JK, Lucisano-Valim YM. Effect of Brazilian green propolis on the production of reactive oxygen species by stimulated neutrophils. J Ethnopharmacol. 2004; 94(1): 59-65. doi: 10. 1016/j. jep. 2004. 04. 026.
12. Park YK, Koo MH, Abreu JA, Ikegaki M, Cury JA, Rosalen PL. Antimicrobial activity of propolis on oral microorganisms. Curr Microbiol. 1998; 36(1): 24-8. doi: 10. 1007/s002849900274.
13. Bankova V. Recent trends and important developments in propolis research. Evid Based Complement Alternat Med. 2005; 2(1): 29-32. doi: 10. 1093/ecam/neh059.
14. Park YK, Alencar SM, Aguiar CL. Botanical origin and chemical composition of Brazilian propolis. J Agric Food Chem. 2002; 50(9): 2502-6. doi: 10. 1021/jf011432b.
15. Kumazawa S, Yoneda M, Shibata I, Kanaeda J, Hamasaka T, Nakayama T. Direct evidence for the plant origin of Brazilian propolis by the observation of honeybee behavior and phytochemical analysis. Chem Pharm Bull (Tokyo). 2003; 51(6): 740-2. doi: 10. 1248/cpb. 51. 740.
16. Zöllner MSAC, Jorge AOC. Candida spp. occurrence in oral cavities of breastfeeding infants and in their mothers' mouths and breasts. Pesqui Odontol Bras. 2003; 17(2): 151-5. doi: 10. 1590/S1517-74912003000200010.
17. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982; 20(1): 7-14.
18. Rüchel R, de Bernardis F, Ray TL, Sullivan PA, Cole GT. Candida acid proteinases. J Med Vet Mycol. 1992; 30(1): 123-32.
19. NCCLS National Committee for Clinical Laboratory Standards. Publication Of M27-A2: reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard-second edition. NCCLS. 2002; 22: 1-29.
20. Council of Europe. European pharmacopoeia, 3rd ed. Strausbourg, 1997; 35: 271-297.
21. Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In: Lorian V, editor. Antibiotics in laboratory medicine. 4th edn ed. Baltimore: Williams & Wilkins; 1996. p. 52-111.
22. Kantarcioglu AS, Yücel A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses. 2002; 45: 160-5. doi: 10. 1046/j. 1439-0507. 2002. 00727. x.
23. Furlaneto-Maia L, Specian AF, Bizerra FC, Oliveira MT, Furlaneto MC. In vitro evaluation of putative virulence attributes of oral isolates of Candida obtained from elderly healthy individuals. Mycopathologia. 2008; 166: 209-17. doi: 10. 1007/s11046-008-9139-7.
24. Lyon JP, de Resende MA. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102(5): 632-8. doi: 10. 1016/j. tripleo. 2005. 12. 015.
25. Da Costa KRC, Ferreira JC, Komesu MC, Candido RC. Candida albicans and Candida tropicalis in Oral Candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity. Mycopathologia. 2009; 167: 73-9. doi: 10. 1007/s11046-008-9154-8.
26. Kumar CPG, Kumar SSJ, Menon T. Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients. Mycopathologia. 2006; 161: 213-8. doi: 10. 1007/s11046-005-0157-4.
27. Oksuz S, Sahin I, Yildirim M, Gulcan A, Yavuz T, Kaya D, Koc AN. Phospholipase and proteinase activities in different Candida species isolated from anatomically distinct sites of healthy adults. Jpn J Infect Dis. 2007; 60(5): 280-3.
28. Pinto E, Ribeiro IC, Ferreira NJ, Fortes CE, Fonseca PA, Figueiral MH. Correlation between enzyme production, germ tube formation and susceptibility to fluconazole in Candida species isolated from patients with denture-related stomatitis and control individuals. J Oral Pathol Med. 2008; 37: 587-92. doi: 10. 1111/j. 1600-0714. 2008. 00687. x.
29. Samaranayake LP, Raeside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia. 1984; 22: 201-7. doi: 10. 1080/00362178485380331.
30. Bodley V, Powers D. Long-term treatment of a breastfeeding mother with fluconazole-resolved nipple pain caused by yeast: a case study. J Hum Lact. 1997; 13(4): 307-11. doi: 10. 1177/089033449701300416.
31. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J, Brazilian Network Candidemia Study. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006; 44(8): 2816-23. doi: 10. 1128/JCM. 00773-06.
32. Pfaller MA, Diekema DJ. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect. 2004; 10(1): 11-23. doi: 10. 1111/j. 1470-9465. 2004. t01-1-00844. x.
33. Goldani LZ, Mário PSS. Candida tropicalis fungemia in a tertiary care hospital. J Infect. 2003; 46(3): 155-60. doi: 10. 1053/jinf. 2002. 1067.
34. Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, Hachem RY, Kontoyiannis DP, Raad II. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med. 2002; 112(5): 380-5. doi: 10. 1016/S0002-9343(01)01130-5.
35. Colombo AL, Guimarães T. Epidemiology of hematogenous infections due to Candida spp. Rev Soc Bras Med Trop. 2003; 36(5): 599-607. doi: 10. 1590/S0037-86822003000500010.
36. Duarte S, Koo H, Bowen WH, Hayacibara MF, Cury JA, Ikegaki M, Rosalen PL. Effect of a novel type of propolis and its chemical fractions on glucosyltransferases and on growth and adherence of Streptococcus mutans. Biol Pharm Bull. 2003; 26(4): 527-31. doi: 10. 1248/bpb. 26. 527.
37. Leitão DPS, Silva-Filho AA, Polizello ACM, Bastos JK, Spadaro ACC. Comparative evaluation of in vitro effects of brazilian green propolis and Baccharis dracunculifolia extracts on cariogenic factors of Streptococcus mutans. Biol Pharm Bull. 2004; 27(11): 1834-9. doi: 10. 1248/bpb. 27. 1834.
38. Da Silva-Filho AA, Sousa JP, Soares S, Furtado NA, Andrade e Silva ML, Cunha WR, Gregório LE, Nanayakkara NP, Bastos JK. Antimicrobial activity of the extract and isolated compounds from Baccharis dracunculifolia DC (Asteraceae). Z Naturforsch C. 2008; 63(1-2): 40-6.
39. Da Silva-Filho AA, Bueno PCP, Gregório LE, Silva MLA, Albuquerque S, Bastos JK. In vitro trypanocidal activity evaluation of crude extract and isolated compounds from Baccharis dracunculifolia D. C. (Asteraceae). J Pharm Pharmacol. 2004; 56: 1195-9. doi: 10. 1211/0022357044067.
40. Missima F, Da Silva Filho AA, Nunes GA, Bueno PCP, Sousa JPB, Bastos JK, Sforcin JM. Effect of Baccharis dracunculifolia D. C. (Asteraceae) extracts and its isolated compounds on macrophage activation. J Pharm Pharmacol. 2007; 59: 463-8. doi: 10. 1211/jpp. 59. 3. 0017.
41. Liu J. Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol. 2005; 100: 92-4. doi: 10. 1016/j. jep. 2005. 05. 024.
42. Cushnie TPT, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents. 2005; 26: 343-56.